Stay updated on ALS Safety & Tolerability of Triumeq Clinical Trial
Sign up to get notified when there's something new on the ALS Safety & Tolerability of Triumeq Clinical Trial page.

Latest updates to the ALS Safety & Tolerability of Triumeq Clinical Trial page
- Check2 days agoChange DetectedRevision updated to v3.5.0; the previous version v3.4.3 was removed.SummaryDifference0.1%

- Check9 days agoChange DetectedAdded University of Sydney as a collaborator and removed the Brain and Mind Centre under The University of Sydney from the collaborators list.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.4.2 was added and the government funding status notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check45 days agoChange DetectedAdded a general site notice about a lapse in government funding and the NIH Clinical Center's operating status, with a link to opm.gov for updates. Updated the page version from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check52 days agoChange DetectedAdded 'Show glossary' and updated footer/version details to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check66 days agoChange DetectedThe page footer now displays Revision: v3.3.4, replacing Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ALS Safety & Tolerability of Triumeq Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALS Safety & Tolerability of Triumeq Clinical Trial page.